MAPT and Alzheimer disease: Finally, recent pieces of evidence demonstrated that human samples obtained by AD-affected patients displayed inhibited damaged mitochondrial clearance [124] and that mitophagy activation diminished insoluble Aβ and Tau hyperphosphorylation to revert cognitive impairments in an AD mouse model [125,126] (Figure 2).